ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Wellbeing status and priority concerns of patients with advanced renal cell carcinoma: results of the EONS PROMs project international online survey.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Treatment experience of patients with failedFrontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLiving with advanced renal cell carcinoma (RCC) can be challenging. Previous research suggests that patients are faced with variable complexities, although the main focus has been on physical problems. We aimed to generate empirical evidence to better understand patients' perceptions of adverse impact on wellbeing, to reveal priority concerns, and to explore moderators that could point to a greater risk for declining health status in this patient population.
methodsA prospective, international, and cross-sectional online survey was conducted, comprising a demographic/clinical data form, the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) questionnaire, and bespoke closed- and open-ended questions.
resultsData from 105 participants were analysed. The typical participant was male, on targeted therapy, and middle-aged (median 42 years), with a median of 54 months since diagnosis, and predominantly originated from the USA or UK. Being unable to work (46%), worrying that their condition would worsen (45%), concerns about psychological support for their partner or family (44%), and being burdened by urinary frequency (43%) were major problems for over 40% of this sample. Concerns about future response to treatment, running out of treatment options, cancer relapse, declining health, dying, and impact on family were also expressed. Older age was linked to higher wellbeing scores.
conclusionRelying on patient-reported outcomes, we were able to reveal the impact of advanced RCC and its management on several interrelated areas of patient wellbeing. These findings need to be validated in other contexts to ensure they are generalisable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.